Target intelligence / Profile preview

GTPase-activating protein GIT1 (GIT1)

Target
GIT1
Molecular classification
Enzyme (GTPase-activating protein, ArfGAP), Signaling scaffold
01

Overview

GTPase-activating protein GIT1 (GIT1) is a multidomain enzyme belonging to the ArfGAP protein family, primarily functioning as a GTPase-activating protein (GAP) for ADP-ribosylation factor (Arf) small GTPases, notably ARF6[1][2][4]. In addition to its enzymatic activity, GIT1 acts as a scaffolding protein integrating signals from small GTPase and protein kinase pathways and facilitating interactions between proteins such as PIX, PAK, paxillin, and MEK[1][2][4]. GIT1 is involved in the regulation of cytoskeletal dynamics, cell migration, endocytosis, and synaptic development, localizing to focal adhesions and endocytic structures[1][2][4]. Dysregulation or altered expression of GIT1 has been implicated in several pathological processes, including cancer progression (via MEK/ERK signaling scaffolding and effects on proliferation/metastasis), cardiovascular disease (via signal transduction and cytoskeletal regulation), and neurodevelopmental disorders[1][2][4]. GIT1 contains several conserved domains, including an N-terminal zinc finger ArfGAP domain, ankyrin repeats, a Spa2-homology domain (SHD), coiled-coil domain, and a carboxyl-terminal region that interacts with paxillin[1][2][4]. As of now, no clinically approved drugs are known to interact directly with GIT1, but it remains a research target in oncology and neurobiology[1][2][4].

Other names
ARF GTPase-activating protein GIT1ARF GAP GIT1CAT-1CAT1Cool-associated and tyrosine-phosphorylated protein 1G protein-coupled receptor kinase-interactor 1GRK-interacting protein 1p95-APP1p95-ADP ribosylation factor GTPase-activating proteinPaxillin-kinase linkerPKLG protein-coupled receptor kinase interacting ArfGAP 1cool-associated and tyrosine-phosphorylated protein 1
02

Mechanism of action

Inhibition/modulation of ARF GTPase pathway through GAP activity; Modulation of protein–protein interaction networks involved in cell migration and signaling

03

Biological functions

Signal transductionCytoskeletal dynamics/cell migrationEndocytosisBrain developmentRegulation of ARF small GTPase activity
04

Disease associations

CancerCardiovascular diseaseNeurodevelopmental/neurological disordersOther
05

Safety considerations

Potential for broad impact on cellular signaling and proliferationPossible interference with focal adhesion and cytoskeletal regulation, leading to disturbed cell migration
06

Biomarkers

GIT1 protein expression (as a research biomarker in some cancers and neurological studies)

Beyond the preview

Go deeper on GTPase-activating protein GIT1 (GIT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GTPase-activating protein GIT1 (GIT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call